Basic fibroblast growth factor in experimental and clinical bacterial meningitis

Chao Ching Huang, Ching Chuan Liu, Shan Tair Wang, Ying Chao Chang, Hsiao Bai Yang, Tsu Fuh Yeh

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Basic fibroblast growth factor (bFGF), a neurotrophic factor in the CNS, is expressed at high levels in response to seizures or strokes. We examined the expression of bFGF during experimental bacterial meningitis and the levels of bFGF in the cerebrospinal fluid (CSF) of children with bacterial meningitis. For the experimental study, a mouse model of meningitis was established by intracranial injection of Streptococcus pneumoniae. Twenty- four hours after induced meningitis, the brains were sectioned and stained immunohistochemically for bFGF. Neutrophils and macrophages infiltrating the leptomeninges and the ventricles exhibited strong bFGF immunoreactivity. The neurons in the areas adjacent to the inflamed ventricles also showed enhanced bFGF expression. For the clinical study, we used an enzyme immunoassay to measure bFGF in CSF in 18 children with bacterial meningitis, 12 with aseptic meningitis, and 18 controls. The CSF levels of bFGF were twice as high in children with bacterial meningitis (medians 6.75-7.21 pg/mL) compared with subjects (2.65 pg/mL, p <0.0001, respectively). In patients with bacterial meningitis who survived, CSF bFGF decreased significantly after 24-50 h of antibiotic therapy (p <0.0005). Patients who developed major sequelae or died had much higher levels of CSF bFGF than those without (134.9 pg/mL versus 7.38 pg/mL, p <0.05). These findings of enhanced immunoreactivity of hFGF in experimental bacterial meningitis and an association of CSF levels of bFGF with disease severity in childhood bacterial meningitis suggest a biologic role for this neurotrophic factor in the pathophysiology of bacterial meningitis.

Original languageEnglish
Pages (from-to)120-127
Number of pages8
JournalPediatric Research
Volume45
Issue number1
Publication statusPublished - Jan 1999
Externally publishedYes

Fingerprint

Bacterial Meningitides
Fibroblast Growth Factor 2
Cerebrospinal Fluid
Nerve Growth Factors
Meningitis
Aseptic Meningitis
Streptococcus pneumoniae
Immunoenzyme Techniques
Seizures
Neutrophils
Stroke
Macrophages
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Huang, C. C., Liu, C. C., Wang, S. T., Chang, Y. C., Yang, H. B., & Yeh, T. F. (1999). Basic fibroblast growth factor in experimental and clinical bacterial meningitis. Pediatric Research, 45(1), 120-127.

Basic fibroblast growth factor in experimental and clinical bacterial meningitis. / Huang, Chao Ching; Liu, Ching Chuan; Wang, Shan Tair; Chang, Ying Chao; Yang, Hsiao Bai; Yeh, Tsu Fuh.

In: Pediatric Research, Vol. 45, No. 1, 01.1999, p. 120-127.

Research output: Contribution to journalArticle

Huang, CC, Liu, CC, Wang, ST, Chang, YC, Yang, HB & Yeh, TF 1999, 'Basic fibroblast growth factor in experimental and clinical bacterial meningitis', Pediatric Research, vol. 45, no. 1, pp. 120-127.
Huang CC, Liu CC, Wang ST, Chang YC, Yang HB, Yeh TF. Basic fibroblast growth factor in experimental and clinical bacterial meningitis. Pediatric Research. 1999 Jan;45(1):120-127.
Huang, Chao Ching ; Liu, Ching Chuan ; Wang, Shan Tair ; Chang, Ying Chao ; Yang, Hsiao Bai ; Yeh, Tsu Fuh. / Basic fibroblast growth factor in experimental and clinical bacterial meningitis. In: Pediatric Research. 1999 ; Vol. 45, No. 1. pp. 120-127.
@article{4f350dad7753418cbf04d76eb3f71e5a,
title = "Basic fibroblast growth factor in experimental and clinical bacterial meningitis",
abstract = "Basic fibroblast growth factor (bFGF), a neurotrophic factor in the CNS, is expressed at high levels in response to seizures or strokes. We examined the expression of bFGF during experimental bacterial meningitis and the levels of bFGF in the cerebrospinal fluid (CSF) of children with bacterial meningitis. For the experimental study, a mouse model of meningitis was established by intracranial injection of Streptococcus pneumoniae. Twenty- four hours after induced meningitis, the brains were sectioned and stained immunohistochemically for bFGF. Neutrophils and macrophages infiltrating the leptomeninges and the ventricles exhibited strong bFGF immunoreactivity. The neurons in the areas adjacent to the inflamed ventricles also showed enhanced bFGF expression. For the clinical study, we used an enzyme immunoassay to measure bFGF in CSF in 18 children with bacterial meningitis, 12 with aseptic meningitis, and 18 controls. The CSF levels of bFGF were twice as high in children with bacterial meningitis (medians 6.75-7.21 pg/mL) compared with subjects (2.65 pg/mL, p <0.0001, respectively). In patients with bacterial meningitis who survived, CSF bFGF decreased significantly after 24-50 h of antibiotic therapy (p <0.0005). Patients who developed major sequelae or died had much higher levels of CSF bFGF than those without (134.9 pg/mL versus 7.38 pg/mL, p <0.05). These findings of enhanced immunoreactivity of hFGF in experimental bacterial meningitis and an association of CSF levels of bFGF with disease severity in childhood bacterial meningitis suggest a biologic role for this neurotrophic factor in the pathophysiology of bacterial meningitis.",
author = "Huang, {Chao Ching} and Liu, {Ching Chuan} and Wang, {Shan Tair} and Chang, {Ying Chao} and Yang, {Hsiao Bai} and Yeh, {Tsu Fuh}",
year = "1999",
month = "1",
language = "English",
volume = "45",
pages = "120--127",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Basic fibroblast growth factor in experimental and clinical bacterial meningitis

AU - Huang, Chao Ching

AU - Liu, Ching Chuan

AU - Wang, Shan Tair

AU - Chang, Ying Chao

AU - Yang, Hsiao Bai

AU - Yeh, Tsu Fuh

PY - 1999/1

Y1 - 1999/1

N2 - Basic fibroblast growth factor (bFGF), a neurotrophic factor in the CNS, is expressed at high levels in response to seizures or strokes. We examined the expression of bFGF during experimental bacterial meningitis and the levels of bFGF in the cerebrospinal fluid (CSF) of children with bacterial meningitis. For the experimental study, a mouse model of meningitis was established by intracranial injection of Streptococcus pneumoniae. Twenty- four hours after induced meningitis, the brains were sectioned and stained immunohistochemically for bFGF. Neutrophils and macrophages infiltrating the leptomeninges and the ventricles exhibited strong bFGF immunoreactivity. The neurons in the areas adjacent to the inflamed ventricles also showed enhanced bFGF expression. For the clinical study, we used an enzyme immunoassay to measure bFGF in CSF in 18 children with bacterial meningitis, 12 with aseptic meningitis, and 18 controls. The CSF levels of bFGF were twice as high in children with bacterial meningitis (medians 6.75-7.21 pg/mL) compared with subjects (2.65 pg/mL, p <0.0001, respectively). In patients with bacterial meningitis who survived, CSF bFGF decreased significantly after 24-50 h of antibiotic therapy (p <0.0005). Patients who developed major sequelae or died had much higher levels of CSF bFGF than those without (134.9 pg/mL versus 7.38 pg/mL, p <0.05). These findings of enhanced immunoreactivity of hFGF in experimental bacterial meningitis and an association of CSF levels of bFGF with disease severity in childhood bacterial meningitis suggest a biologic role for this neurotrophic factor in the pathophysiology of bacterial meningitis.

AB - Basic fibroblast growth factor (bFGF), a neurotrophic factor in the CNS, is expressed at high levels in response to seizures or strokes. We examined the expression of bFGF during experimental bacterial meningitis and the levels of bFGF in the cerebrospinal fluid (CSF) of children with bacterial meningitis. For the experimental study, a mouse model of meningitis was established by intracranial injection of Streptococcus pneumoniae. Twenty- four hours after induced meningitis, the brains were sectioned and stained immunohistochemically for bFGF. Neutrophils and macrophages infiltrating the leptomeninges and the ventricles exhibited strong bFGF immunoreactivity. The neurons in the areas adjacent to the inflamed ventricles also showed enhanced bFGF expression. For the clinical study, we used an enzyme immunoassay to measure bFGF in CSF in 18 children with bacterial meningitis, 12 with aseptic meningitis, and 18 controls. The CSF levels of bFGF were twice as high in children with bacterial meningitis (medians 6.75-7.21 pg/mL) compared with subjects (2.65 pg/mL, p <0.0001, respectively). In patients with bacterial meningitis who survived, CSF bFGF decreased significantly after 24-50 h of antibiotic therapy (p <0.0005). Patients who developed major sequelae or died had much higher levels of CSF bFGF than those without (134.9 pg/mL versus 7.38 pg/mL, p <0.05). These findings of enhanced immunoreactivity of hFGF in experimental bacterial meningitis and an association of CSF levels of bFGF with disease severity in childhood bacterial meningitis suggest a biologic role for this neurotrophic factor in the pathophysiology of bacterial meningitis.

UR - http://www.scopus.com/inward/record.url?scp=0032937662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032937662&partnerID=8YFLogxK

M3 - Article

C2 - 9890619

AN - SCOPUS:0032937662

VL - 45

SP - 120

EP - 127

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -